drugset / Trial / NCT05322707
BE Study Budesonide 80 μg and Formoterol Fumarate Dihydrate 4.5 μg Inhalation Product in Asthma Patient
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of the study is to demonstrate the Pharmacodynamic bioequivalence of the test product to the reference product in adult patient with Asthma
Timeline
- Start
- 2022-04-15
- Primary completion
- 2023-08-15
- Completion
- 2023-08-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Budesonide | Small molecule | 80 ug | Inhaled |
| Subject | Formoterol | Other / unclassified | 4.5 ug | Inhaled |
| Comparator | Symbicort | Unknown | — | Inhaled |